» Articles » PMID: 27523648

The Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis

Overview
Journal Curr Diab Rep
Publisher Current Science
Specialty Endocrinology
Date 2016 Aug 16
PMID 27523648
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

The gastrointestinal system represents one of the largest interfaces between the human internal microenvironment and the external world. This system harbors trillions of commensal bacteria that reside in symbiosis with the host. Intestinal bacteria play a crucial role in maintaining systemic and intestinal immune and metabolic homeostasis because of their effect on nutrient absorption and immune development and function. Recently, altered gut bacterial composition (dysbiosis) was hypothesized to be involved in mechanisms through which islet autoimmunity is triggered. Evidence from animal models indicates that alterations in the gut bacterial composition precede disease onset, thus implicating a causal role for the gut microbiome in islet destruction. However, it remains unclear whether dysbiosis is directly linked to the mechanisms of human type 1 diabetes (T1D). In this review, we discuss data implicating the gut microbiota in disease progression with an emphasis on our recent studies performed in humans and in rodent models of T1D.

Citing Articles

Gut microbiota mediated T cells regulation and autoimmune diseases.

Bhutta N, Xu X, Jian C, Wang Y, Liu Y, Sun J Front Microbiol. 2025; 15:1477187.

PMID: 39749132 PMC: 11694513. DOI: 10.3389/fmicb.2024.1477187.


The role of GABA in type 1 diabetes.

Mick G, McCormick K Front Endocrinol (Lausanne). 2024; 15:1453396.

PMID: 39619323 PMC: 11604429. DOI: 10.3389/fendo.2024.1453396.


Gut microbiome shifts in people with type 1 diabetes are associated with glycaemic control: an INNODIA study.

Vatanen T, de Beaufort C, Marcovecchio M, Overbergh L, Brunak S, Peakman M Diabetologia. 2024; 67(9):1930-1942.

PMID: 38832971 PMC: 11410864. DOI: 10.1007/s00125-024-06192-7.


Systemic Evaluation of the Effect of Diabetes Mellitus on Breast Cancer in a Mouse Model.

Wei N, Lu J, Lin Z, Wang X, Cai M, Jiang S Front Oncol. 2022; 12:829798.

PMID: 35578660 PMC: 9106558. DOI: 10.3389/fonc.2022.829798.


Gut Microbial Antigenic Mimicry in Autoimmunity.

Garabatos N, Santamaria P Front Immunol. 2022; 13:873607.

PMID: 35572569 PMC: 9094498. DOI: 10.3389/fimmu.2022.873607.


References
1.
Wu G, Chen J, Hoffmann C, Bittinger K, Chen Y, Keilbaugh S . Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011; 334(6052):105-8. PMC: 3368382. DOI: 10.1126/science.1208344. View

2.
Kelly D, Campbell J, King T, Grant G, Jansson E, Coutts A . Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol. 2003; 5(1):104-12. DOI: 10.1038/ni1018. View

3.
Wen L, Ley R, Volchkov P, Stranges P, Avanesyan L, Stonebraker A . Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature. 2008; 455(7216):1109-13. PMC: 2574766. DOI: 10.1038/nature07336. View

4.
Vaahtovuo J, Munukka E, Korkeamaki M, Luukkainen R, Toivanen P . Fecal microbiota in early rheumatoid arthritis. J Rheumatol. 2008; 35(8):1500-5. View

5.
Canfora E, Jocken J, Blaak E . Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol. 2015; 11(10):577-91. DOI: 10.1038/nrendo.2015.128. View